Abiopharma

🔍 Sterling Brian R (Director)

Company: PIPER SANDLER COMPANIES (PIPR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 323 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 102,659.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The reporting person elected to defer receipt of quarterly director cash retainer fees resulting in the accrual to his account of 323 shares of phantom stock. The shares of phantom stock become payable, in common stock, on the last day of the year in which the reporting person's service as a director terminates.